Smith Nicholas Conrad has filed 18 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 2806 shares of Alto Neuroscience, Inc. ($ANRO) on March 01, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | F | Common Stock | 2806 | $19.69 | 24,060.0000 | 31,066,335 | 10.44% | 0.01% |
| Feb. 11, 2026 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 31,066,335 | 9999.99% | 0.64% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 33833 | $0.00 | 33,833.0000 | 27,072,129 | 9999.99% | 0.12% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 33833 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.12% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 202329 | $0.00 | 202,329.0000 | 27,072,129 | 9999.99% | 0.75% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 202329 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.75% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 27,072,129 | 9999.99% | 0.33% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 90000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.33% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 27,072,129 | 9999.99% | 0.50% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 44962 | $0.00 | 44,962.0000 | 27,072,129 | 9999.99% | 0.17% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 135000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.50% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 44962 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.17% |
| Feb. 5, 2025 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P | Common Stock | 4550 | $16.56 | 26,866.0000 | 0 | 20.39% | 0.00% |
| March 28, 2024 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P | Common Stock | 1600 | $15.80 | 22,316.0000 | 0 | 7.72% | 0.00% |
| March 1, 2024 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | A | Common Stock | 19153 | $0.00 | 20,716.0000 | 0 | 1225.40% | 0.00% |
| March 1, 2024 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P | Common Stock | 1563 | $16.00 | 1,563.0000 | 0 | 9999.99% | 0.00% |